000			02196 a2200601 4500
005			20250516060044.0
264		0	_c20120322
008			201203s 0 0 eng d
022			_a1439-7803
024	7		_a10.1055/s-0031-1281752 _2doi
040			_aNLM _beng _cNLM
100	1		_aPohl, M
245	0	0	_aBiomarkers of anti-angiogenic therapy in metastatic colorectal cancer (mCRC): original data and review of the literature. _h[electronic resource]
260			_bZeitschrift fur Gastroenterologie _cOct 2011
300			_a1398-406 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Review
650	0	4	_aAC133 Antigen
650	0	4	_aAged
650	0	4	_aAngiogenesis Inhibitors _xadministration & dosage
650	0	4	_aAntibodies, Monoclonal, Humanized _xadministration & dosage
650	0	4	_aAntigens, CD _xblood
650	0	4	_aAntigens, CD34 _xblood
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aBevacizumab
650	0	4	_aBiomarkers _xblood
650	0	4	_aCell Count
650	0	4	_aColorectal Neoplasms _xblood supply
650	0	4	_aDisease Progression
650	0	4	_aEndothelial Cells _xdrug effects
650	0	4	_aEndothelium, Vascular _xdrug effects
650	0	4	_aFemale
650	0	4	_aFlow Cytometry
650	0	4	_aGlycoproteins _xblood
650	0	4	_aHumans
650	0	4	_aImmunohistochemistry
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPeptides _xblood
650	0	4	_aPilot Projects
650	0	4	_aStem Cells _xdrug effects
650	0	4	_aTreatment Outcome
650	0	4	_aVascular Endothelial Growth Factor A _xantagonists & inhibitors
650	0	4	_aVascular Endothelial Growth Factor Receptor-2 _xblood
700	1		_aWerner, N
700	1		_aMunding, J
700	1		_aTannapfel, A
700	1		_aGraeven, U
700	1		_aNickenig, G
700	1		_aSchmiegel, W
700	1		_aReinacher-Schick, A
773	0		_tZeitschrift fur Gastroenterologie _gvol. 49 _gno. 10 _gp. 1398-406
856	4	0	_uhttps://doi.org/10.1055/s-0031-1281752 _zAvailable from publisher's website
999			_c21201300 _d21201300